Photodynamic therapy for treatment of solid tumors - Potential and technical challenges

Technology in Cancer Research and Treatment

Volumn 7, Issue 4, 2008, Pages 309-320

  Huang, Zheng ^a   Xu, Heping ^b   Meyers, Arlen D ^a   Musani, Ali I ^a,c   Wang, Luowei ^a,d   Tagg, Randall ^a   Barqawi, Al B ^a   Chen, Yang K ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dosimetry; Interstitial; Photodynamic therapy; Solid tumor

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TALAPORFIN; TEMOPORFIN; VERTEPORFIN; WST 11;

BIOLOGICAL DOSIMETRY; CLINICAL TRIAL; CYTOTOXICITY; DIRECT DOSIMETRY; DOSIMETRY; DRUG EFFECT; HUMAN; IMMUNE RESPONSE; IMPLICIT DOSIMETRY; LIGHT; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; SOLID TUMOR; TISSUE OXYGENATION;

EID: 50249098813     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700405     Document Type: Review

References (112)

1. Huang, Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4, 283-294 (2005).
2. Selman, S. H. Photodynamic therapy for prostate cancer: One urologist's perspective. Photodiag Photodyn Ther 4, 26-30 (2007).
3. Muller, P. J., Wilson, B. C. Photodynamic therapy of brain tumors - a work in progress. Lasers Surg Med 38, 384-389 (2006).
4. Huang, Z. Photodynamic therapy in China: 25 years of unique history - Part two: clinical experience. Photodiag Photodyn Ther 3, 71-84 (2006).
5. Biel, M. Advances in photodynamic therapy for the treatment of head and neck cancers. Lasers Surg Med 38, 349-355 (2006).
6. Hautmann, H., Pichler, J. P., Stepp, H., et al. In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res 8, 33 (2007).
7. Arens, C., Reussner, D., Woenkhaus, J., et al. Indirect fluorescence laryngoscopy in the diagnosis of precancerous and cancerous laryngeal lesions. Eur Arch Otorhinolaryngol 264, 621-626 (2007).
8. Allison, R. R., Downie, G. H., Cuenca, R., et al. Photosensitizers in clinical PDT. Photodiag Photodyna Ther 1, 27-42 (2004).
9. Moser, J. G. Definitions and general properties of 2nd & 3rd generation photosensitizers, In: Photodynamic Tumor Therapy - 2nd & 3rd Generation Photosensitizers, pp. 3-8. Ed., Moser, J. G. Harwood Academic Publishers, London (1997).
10. Loewen, G. M., Pandey, R., Bellnier, D., Henderson, B., Dougherty, T. Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med 38, 364-370 (2006).
11. Jankun, J., Lilge, L., Douplik, A., et al. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy. J Urol 172, 739-743 (2004).
12. Du, K. L., Mick, R., Busch, T. M., et al. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med 38, 427-434 (2006).
13. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Two year results of two randomized clinical trials - TAP report 2. Arch Ophthalmol 119, 198-207 (2001).
14. Yuan, K. H., Li, Q., Yu, W. L., et al. Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: A retrospective analysis. Photodiagn Photodyn Ther 5, 50-57 (2008).
15. Huang, Z., Chen, Q., Luck, D., et al. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 36, 390-397 (2005).
16. Trachtenberg, J., Bogaards, A., Weersink, R. A., et al. Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response. J Urol 178, 1974-1979 (2007).
17. Brandis, A., Mazor, O., Neumark, E., et al. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochem Photobiol 81, 983-993 (2005).
18. Preise, D., Mazor, O., Koudinova, N., et al. Bypass of tumor drug resistance by antivascular therapy. Neoplasia 5, 475-480 (2003).
19. Wilson, B. C., Weersink, R. A., Lilge, L. Fluorescence in Photodynamic Therapy Dosimetry. In: Handbook of Biomedical Fluorescence, pp. 529-561. Eds., M. Mycek and B. W. Pogue. Marcel Dekker, Inc., New York (2003)
20. Tagg, R., Asadi-Zeydabadi, M., Meyers, A. D. Biophotonic and other physical methods for characterizing oral mucosa. Otolaryngol Clin North Am 38, 215-240 (2005).
21. Jankun, J., Keck, R. W., Skrzypczak-Jankun, E., Lilge, L., Selman, S. H. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. BJU Int 95, 1237-1244 (2005).
22. Wilson, B. C., Muller, P. J., Yanch, J. C. Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. Phys Med Biol 31, 125-133 (1986).
23. Roche, J. V. E., Whitehurst, C., Watt, P., Moore, J. V., Krasner, N. Photodynamic Therapy (PDT) of Gastrointestinal Tumours: A New Light Delivery System. Lasers Med Sci 13, 137-142 (1998).
24. Rendon, A., Beck, J. C., Lilge, L. Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate. Phys Med Biol 53, 1131-1149 (2008).
25. Nyst, H. J., van, Veen, R. L., Tan, I. B., et al. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: Phantom and volunteer experiments. Lasers Surg Med 39, 647-653 (2007).
26. Weersink, R. A., Bogaards, A., Gertner, M., et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 79, 211-222 (2005).
27. Samkoe, K. S., Clancy, A. A., Karotki, A., Wilson, B. C., Cramb, D. T. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. J Biomed Opt 12, 034025 (2007).
28. Drobizhev, M., Makarov, N. S., Stepanenko, Y., Rebane, A. Near-infrared two-photon absorption in phthalocyanines: enhancement of lowest gerade-gerade transition by symmetrical electron-accepting substitution. J Chem Phys 124, 224701 (2006).
29. Juzeniene, A., Juzenas, P., Ma, L. W., Iani, V., Moan, J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 19, 139-149 (2004).
30. Mang, T. S. Lasers and light sources for PDT: past, present and future. Photodiag Photodyn Ther 1, 43-48 (2004).
31. Schmidt, M. H., Bajic, D. M., Reichert, K. W. II., et al. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery 38, 552-556 (1996).
32. Lustig, R. A., Vogl, T. J., Fromm, D., et al. A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors. Cancer 98, 1767-1771 (2003).
33. Chen, J., Keltner, L., Christophersen, J., et al. New technology for deep light distribution in tissue for phototherapy. Cancer J 8, 154-163 (2002).
34. Martin, N. E., Hahn, S. M. Interstitial photodynamic therapy for prostate cancer: a developing modality. Photodiag Photodyn Ther 1, 123-136 (2004).
35. Johansson, A., Axelsson, J., Andersson-Engels, S., Swartling, J. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. Med Phys 34, 4309-4321 (2007).
36. Li, J., Zhu, T. C. Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy. Phys Med Biol 53, 2103-2114 (2008).
37. Huang, Z., Chen, Q., Shakil, A., et al. Hyperoxygenation enhances the tumor cell killing of Photofrin-mediated photodynamic therapy. Photochem Photobiol 78, 496-502 (2003).
38. Chen, Q., Huang, Z., Chen, H., Beckers, J., Hetzel, F. W. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol 76, 197-203 (2002).
39. Vakrat-Haglili, Y., Weiner, L., Brumfeld, V., et al. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J Am Chem Soc 127, 6487-6497 (2005).
40. Vaupel, P., Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26, 225-239 (2007).
41. Hutchison, G. J., Valentine, H. R., Loncaster, J. A., et al. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res 10, 8405-8412 (2004).
42. Woodhams, J. H., Macrobert, A. J., Bown, S. G. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry. Photochem Photobiol Sci 6, 1246-1256 (2007).
43. 2 histography. Antioxid Redox Signal 9, 1221-1235 (2007).
44. Tempel-Brami, C., Pinkas, I., Scherz, A., Salomon, Y. Detection of light images by simple tissues as visualized by photosensitized magnetic resonance imaging. PLoS ONE 2, e1191 (2007).
45. Gross, S., Gilead, A., Scherz, A., Neeman, M., Salomon, Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med 9, 1327-1331 (2003).
46. Sitnik, T. M., Hampton, J. A., Henderson, B. W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer 77, 1386-1394 (1998).
47. Henderson, B. W., Busch, T. W., Vaughan, L. A., et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 60, 525-529 (2000).
48. Curnow, A., Haller, J. C., Bown, S. G. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. Photochem Photbiol B 58, 149-155 (2000).
49. Maier, A., Anegg, U., Fell, B., et al. Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastroesophageal junction. Lasers Surg Med 26, 461-466 (2000).
50. Maier, A., Tomaselli, F., Anegg, U., et al. Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg 18, 649-654 (2000).
51. Tomaselli, F., Maier, A., Sankin, O., et al. Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer - a clinical pilot study. Lasers Surg Med 28, 399-403 (2001).
52. Tomaselli, F., Maier, A., Pinter, H., Stranzl, H., Smolle-Juttner, F. M. Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients). Eur J Cardiothorac Surg 5, 549-554 (2001).
53. Bisland, S. K., Lilge, L., Lin, A., Rusnov, R., Wilson, B. C. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol 80, 22-30 (2004).
54. Chiu, S. M., Xue, L. Y., Azizuddin, K., Oleinick, N. L. Photodynamic therapy-induced death of HCT 116 cells: Apoptosis with or without Bax expression. Apoptosis 10, 1357-1368 (2005).
55. Gomer, C. J., Luna, M., Ferrario, A., et al. Cellular targets and molecular responses associated with photodynamic therapy. J Clin Laser Med Surg 14, 315-321 (1996).
56. Verma, S., Watt, G. M., Mai, Z., Hasan, T. Strategies for enhanced photodynamic therapy effects. Photochem Photobiol 83, 996-1005 (2007).
57. Kessel, D., Reiners, J. J. Jr. Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem Photobiol 83, 1024-1028 (2007).
58. Xue, L. Y., Chiu, S. M., Azizuddin, K., Joseph, S., Oleinick, N. L. Protection by Bcl-2 against apoptotic but not autophagic cell death after photodynamic therapy. Autophagy 4, 125-127 (2008).
59. Star, W. M., Marijnissen, J. P., van den Berg-Blok, A. E., Reinhold, H. S. Destructive effect of photoradiation on the microcirculation of a rat mammary tumor growing in "sandwich" observation chambers. Prog Clin Biol Res 170, 637-645 (1984).
60. Henderson, B. W., Fingar, V. H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47, 3110-3114 (1987).
61. Fingar, V. H. Vascular effects of photodynamic therapy. J. Clin. Laser Med Surg 14, 323-328 (1996).
62. Abels, C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem Photobiol Sci 3, 765-771 (2004).
63. Chen, B., Pogue, B. W., Hoopes, P. J., Hasan, T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16, 279-305 (2006).
64. Huang, Z., Chen, Q., Luck, D., et al. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 36, 390-397 (2005).
65. Korbelik, M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 14, 329-334 (1996).
66. Canti, G., De Simone, A., Korbelik, M. Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1, 79-80 (2002).
67. van Duijnhoven, F. H., Aalbers, R. I. J. M., Rovers, J. P., Terpstra, O. T., Kuppen, P. J. K. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiol 207, 105-113 (2003).
68. Nowis, D., Stoklosa, T., Legat, M., et al. The influence of photodynamic therapy on the immune response. Photodiag Photodyn Ther 2, 283-298 (2005).
69. Yamamoto, N., Homma, S., Sery, T. W., Donoso, T. W., Hoober, J. K. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. Eur J Cancer 27, 467-471 (1991).
70. Krosl, G., Korbelik, M., Dougherty, G. J. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 71, 549-555 (1995).
71. Korbelik, M., Krosl, G., Krosl, J., Dougherty, G. J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 15, 5647-5652 (1996).
72. Goilnick, S. O., Evans, S. S., Baumann, H., et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 42, 1772-1779 (2003).
73. Castano, A. P., Mroz, P., Hamblin, M. R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6, 535-45 (2006).
74. Abdel-Hady, E. S., Martin-Hirsch, P., Duggan-Keen, M., et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 61, 192-196 (2001).
75. Korbelik, M., Sun, J., Cecic, I., Serrano, K. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci 3, 812-816 (2004).
76. Goilnick, S. O., Vaughan, L., Henderson, B. W. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 62, 1604-1608 (2002).
77. Qiang, Y. G., Yow, C. M. N., Huang, Z. Combination of photodynamic therapy and immunomodulation - current status and future trends. Med Res Rev 28, 632-644 (2008).
78. Star, W. M. Light dosimetry in vivo. Phys Med Biol 42, 763-787 (1997).
79. Patterson, M. S., Wilson, B. C. Photodynamic therapy, In: The modern technology of radiation oncology, Chap. 23. Ed., Van Dyk, J. Medical Physics Publishing, Madison, Wisconsin (1999).
80. AAPM Report No. 88, Photodynamic therapy dosimetry, AAPM task group report of the general medical physics committee of the science council. Medical Physics Publishing. (2005)
81. Wilson, B. C., Patterson, M. S., Lilge, L. Implicit and explicit dosimetry in photodynamic theory: a new paradigm. Lasers Med Sci 12, 182-199 (1997).
82. Niedre, M. J., Secord, A. J., Patterson, M. S., Wilson, B. C. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res 63, 7986-7994 (2003).
83. Davis, S. J., Zhu, L., Minhaj, A., et al. Ultra-senstitive, diode laser based monitor for singlet oxygen. Proc SPIE 4952, 140-148 (2003).
84. Yeung, W. T., Lee, T. Y., Del Maestro, R. F., Kozak, R., Brown, T. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neurooncol 14, 177-187 (1992).
85. Herman, M. A., Fromm, D., Kessel, D. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. J Photochem Photobiol 52, 99-104 (1999).
86. Berard, V., Lecomte, R., van Lier, J. E. Positron emission tomography imaging of tumor response after photodynamic therapy. J Environ Pathol Toxicol Oncol 25, 239-250 (2006).
87. Molckovsky, A., Wilson, B. C. Monitoring of cell and tissue responses to photodynamic therapy by electrical impedance spectroscopy. Phys Med Biol 46, 983-1002 (2001).
88. Moriyama, E. H., Bisland, S. K., Lilge, L., Wilson, B. C. Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. Photochem Photobiol 80, 242-249 (2004).
89. Pogue, B. W., Pitts, J. D., Mycek, M. A., et al. In vivo NADH fluorescence monitoring as an assay for cellular damage in photodynamic therapy. Photochem Photobiol 74, 817-824 (2001).
90. Dysart, J. S., Singh, G., Patterson, M. S. Calculation of singlet oxygen dose from photosensitizer fluorescence emission and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 81, 196-205 (2005).
91. Finlay, J. C., Mitra, S., Patterson, M. S., Foster, T. H. Photobleaching kinetics of Photofrin in vivo and in multicell tumor spheroids indicate two simultaneous bleaching mechanisms. Phys Med Biol 49, 4837-4860 (2004).
92. Dysart, J. S., Patterson, M. S. Photobleaching kinetics, photoproduct formation and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochemical and Photobiological Sciences 5, 73-81 (2006).
93. Svaasand, L. O., Potter, W. R. The implications of photobleaching for photodynamic therapy, In: Photodynamic therapy: Basic principles and clinical applications, pp, 369-385. Eds., B.W. Henderson, T.J. Dougherty, Marcel Dekker, New York (1992).
94. Tan, I. B., Oppelaar, H., Ruevekamp, M. C., et al. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors. Head Neck 21, 434-441 (1999).
95. Eljamel, M. S. New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Technol Cancer Res Treat 2, 303-309 (2003).
96. Vogl, T. J., Eichler, K., Mack, M. G., Zangos, S., Herzog, C., Thalhammer, A., Engelmann, K. Interstitial photodynamic laser therapy in interventional oncology. Eur Radiol 14, 1063-1073 (2004).
97. Fielding, D. I., Buonaccorsi, G. A., MacRobert, A. J., et al. Fine-needle interstitial photodynamic therapy of the lung parenchyma: photosensitizer distribution and morphologic effects of treatment. Chest 115, 502-510 (1999).
98. Bown, S. G., Rogowska, A. Z., Whitelaw, D. E., et al. Photodynamic therapy for cancer of the pancreas. Gut 50, 549-557 (2002).
99. Zhu, T. C., Finlay, J. C., Hhan, S. M. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B 79, 231-241 (2005).
100. Arnfield, M. R., Chapman, J. D., Tulip, J., Fenning, M. C., McPhee, M. S. Optical properties of experimental prostate tumors in vivo. Photochem Photobiol 57, 306-311 (1993).
101. Zhu, T. C., Hahn, S. M., Kapatkin, A. S., et al. In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol 77, 81-88 (2003).
102. Zhu, T. C., Finlay, J. C. Prostate PDT dosimetry. Photodiag Photodyn Ther 3, 234-246 (2006).
103. Finlay, J. C., Zhu, T. C., Dimofte, A., et al. Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol 82, 1270-1278 (2006).
104. Wang, K. K., Mitra, S., Foster, T. H. A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. Med Phys 34, 282-293 (2007).
105. Thompson, M. S., Johansson, A., Johansson, T., et al. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. Appl Opt 44, 4023-4031 (2005).
106. Woodhams, J. H., MacRobert, A. J., Novelli, M., Bown, S. G. Photodynamic therapy with WST09 (Tookad): Quantitative studies in normal colon and transplanted tumours. Int J Cancer 118, 477-482 (2006).
107. Borle, F., Radu, A., Monnier, P., van den Bergh, H., Wagnieres, G. Evaluation of the photosensitizer Tookad® for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug light interval effects. Photchem Photbiol 78, 377-383 (2003).
108. Huang, Z., Chen, Q., Dole, K. C., et al. The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues - in vivo study in a canine model. Photochem Photobiol Sci 6, 1318-1324 (2007).
109. Rendon, A., Weersink, R., Lothar, L. Towards conformal light delivery using tailored cylindrical diffusers: attainable light dose distributions. Phys Med Biol 51, 5967-5975 (2006).
110. Huang, N., Cheng, G., Li, X., et al. Influence of drug-light-interval on photodynamic therapy of port wine stains - Simulation and validation of mathematic models. Photodiag Photodyn Ther 5, 120-126 (2008).
111. Xu, H., Patterson, M. S. Determination of the optical properties of tissue-simulating phantoms from interstitial frequency domain measurements of relative fluence and phase difference. Optics Express 14, 6485-6501 (2006).
112. Allison, R. R., Bagnato, V. S., Cuenca, R., Downie, G. H., Sibata, C. H. The future of photodynamic therapy in oncology. Future Oncol 2, 53-71 (2006).